Data as of Sep 19
| +0.28 / +0.58%|
The 4 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 59.00, with a high estimate of 65.00 and a low estimate of 54.00. The median estimate represents a +20.63% increase from the last price of 48.91.
The current consensus among 5 polled investment analysts is to Buy stock in Agios Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.